Dr. Brian G. Feagan

Robarts Research Institute, University of Western Ontario

REDUCTIONS IN CORTICOSTEROID USE IN PATIENTS WITH ULCERATIVE COLITIS OR CROHN’S DISEASE TREATED WITH VEDOLIZUMAB
2013-01-01
English, Medical management, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013
Should we treat according to symptoms, biomarkers or intestinal lesions?
2013-01-01
English, Syllabus contribution, 2013
PREGNANCY OUTCOMES IN PATIENTS WITH CROHN’S DISEASE TREATED WITH INFLIXIMAB: RESULTS FROM THE TREAT™ REGISTRY
2013-01-01
English, Medical management, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013
LONG-TERM SAFETY OF VEDOLIZUMAB FOR THE TREATMENT OF ULCERATIVE COLITIS OR CROHN’S DISEASE
2013-01-01
English, Medical management, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013
Starting therapy in Crohn´s Disease: To Combine or Not to Combine
2010-01-01
English, Presentation, Clinical aspects, Medical management, Colon, Inflammatory bowel disease, Small intestine, 2010
Crohn´s disease guidelines: Europe versus North America
2011-01-01
English, Presentation, Clinical aspects, Crohn’s disease, Medical management, Colon, Surgical management, Small intestine, Management review, 2011
Methotrexate for IBD: A neglected drug?
2011-01-01
English, Presentation, Clinical aspects, Crohn’s disease, Medical management, Colon, Ileum, 2011
Should we treat IBD according to symptoms, biomarkers or intestinal lesions?
2013-01-01
English, Presentation, Clinical aspects, Screening, Surveillance, Inflammatory bowel disease, 'IBD-ology', 2013
PREGNANCY OUTCOMES IN PATIENTS WITH CROHN’S DISEASE TREATED WITH INFLIXIMAB: RESULTS FROM THE TREAT™ REGISTRY
2013-01-01
English, Medical management, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013